Budesonide/formoterol
(Redirected from DuoResp Spiromax)
Budesonide/Formoterol[edit | edit source]
Budesonide/formoterol is a combination medication used in the management of asthma and chronic obstructive pulmonary disease (COPD). It combines two active ingredients: budesonide, a corticosteroid, and formoterol, a long-acting beta-agonist (LABA). This combination is used to improve lung function and reduce symptoms such as wheezing and shortness of breath.
Pharmacology[edit | edit source]
Budesonide[edit | edit source]
Budesonide is a corticosteroid that works by reducing inflammation in the airways. It helps to decrease the swelling and irritation in the lungs, making it easier to breathe. Budesonide is often used in the long-term management of asthma and COPD to prevent exacerbations.
Formoterol[edit | edit source]
Formoterol is a long-acting beta-agonist that helps to relax the muscles around the airways. This relaxation leads to the widening of the airways, making it easier for air to flow in and out of the lungs. Formoterol provides rapid relief of symptoms and is effective for up to 12 hours.
Indications[edit | edit source]
Budesonide/formoterol is indicated for the treatment of:
- Asthma in patients who require both a corticosteroid and a long-acting beta-agonist.
- Chronic obstructive pulmonary disease (COPD) in patients who experience frequent exacerbations despite regular bronchodilator therapy.
Administration[edit | edit source]
Budesonide/formoterol is administered via inhalation using a metered-dose inhaler or a dry powder inhaler. The dosage and frequency depend on the severity of the condition and the specific needs of the patient. It is important for patients to follow their healthcare provider's instructions carefully.
Side Effects[edit | edit source]
Common side effects of budesonide/formoterol include:
Patients are advised to rinse their mouth after inhalation to reduce the risk of oral thrush.
Precautions[edit | edit source]
Patients using budesonide/formoterol should be aware of the potential for increased risk of asthma-related death associated with long-acting beta-agonists. It is important to use this medication as part of a comprehensive asthma management plan.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
